Document is current
Any future updates will be listed below
-
Authors
Jacobsen, Malte https://orcid.org/0000-0003-0780-0003
Gholamipoor, Rahil
Dembek, Till A.
Rottmann, Pauline
Verket, Marlo https://orcid.org/0000-0002-3361-3722
Brandts, Julia
Jäger, Paul
Baermann, Ben-Niklas
Kondakci, Mustafa
Heinemann, Lutz
Gerke, Anna L.
Marx, Nikolaus
Müller-Wieland, Dirk
Möllenhoff, Kathrin https://orcid.org/0000-0001-7861-3892
Seyfarth, Melchior https://orcid.org/0000-0002-9473-8262
Kollmann, Markus https://orcid.org/0000-0002-5317-5408
Kobbe, Guido
-
Funding
Funding for this research was provided by:
Faculty of Health at Witten/Herdecke University
Jürgen Manchot Stiftung
Financial support by the Jürgen Machnot Foundation
Leukämie Lymphom Liga e.V, Germany Spiess Stiftung, Düsseldorf, Germany
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 19 May 2023
First Online: 2 June 2023
Competing interests
: This study was an Investigator Initiated trial. This research received funding from the internal grant program (Ph.D. and Dr. rer. nat. Program Biomedicine) of the Faculty of Health at Witten/Herdecke University, Germany, by a grant from the Leukämie Lymphom Liga e.V, Germany, and by the Spiess Stiftung, Düsseldorf, Germany. The authors declare no competing interests.
